The Technical Analyst
Select Language :
Autolus Therapeutics PLC [AUTL]

Exchange: NasdaqGS Sector: Healthcare Industry: Biotechnology

Autolus Therapeutics PLC Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Autolus Therapeutics PLC is listed at the NASDAQ Exchange

-2.83% $2.75

Last updated: 3 jul 2022 - 19:37

TimeZone: America/New_York


FUNDAMENTALS
MarketCap: 250.03 mill
EPS: -1.842
P/E: 0.000
Earnings Date: May 04, 2022
SharesOutstanding: 90.92 mill
Avg Daily Volume: 0.215 mill
RATING 2022-07-01
B+
Neutral
RATINGDETAILS
Rating CashFlow: Strong Buy
Return On Equity: Sell
Return On Asset: Sell
DE: Neutral
P/E: Sell
Price To Book: Strong Buy
QUARTER GROWTHS
4/201/212/213/214/211/22
Revenuen/an/a
Gr.Profitn/an/an/an/an/a
Ebit
Asset
Debt
DISCOUNTED CASH FLOW VALUE
$7.06
(156.55%) $4.31
Date: 2022-07-03
True Range Average
+/- $0.223
( +/- 8.11%)
Range: 2.53 - 2.97
ATR Model: 14 days

Forecast: 16:00 - $2.76

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $2.76
Forecast 2: 16:00 - $2.76
Forecast 3: 16:00 - $2.76
SCORE
-10.00
Sell
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $2.75 (-2.83% )
Volume 0.0636 mill
Avg. Vol. 0.215 mill
% of Avg. Vol 29.54 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Autolus Therapeutics PLC

Last 12 Months

Last 12 months chart data with high, low, open and close for Autolus Therapeutics PLC

RSI

Intraday RSI14 chart for Autolus Therapeutics PLC

Last 10 Buy & Sell Signals For AUTL

26 Signals | Accuracy: 15.38% | Accuracy Buy: 23.08% | Accuracy Sell: 7.69%

Avg return buy: -0.40 % | Avg return sell: 0.19 %

$1 invested is now $0.95 or -5.10% since 30-06-22

Date Signal @ Closed %
Jul 1 - 15:45sell$2.75N/AActive
Jul 1 - 15:38buy$2.78$2.75 @ Jul 1 - 15:45-1.08%
Jul 1 - 15:15sell$2.78$2.78 @ Jul 1 - 15:380.00%
Jul 1 - 15:06buy$2.79$2.78 @ Jul 1 - 15:15-0.36%
Jul 1 - 11:40sell$2.89$2.79 @ Jul 1 - 15:06-3.29%
Jul 1 - 11:26buy$2.89$2.89 @ Jul 1 - 11:400.00%
Jul 1 - 11:03sell$2.88$2.89 @ Jul 1 - 11:260.17%
Jul 1 - 10:55buy$2.90$2.88 @ Jul 1 - 11:03-0.52%
Jul 1 - 10:43sell$2.88$2.90 @ Jul 1 - 10:550.52%
Jul 1 - 10:12buy$2.86$2.88 @ Jul 1 - 10:430.62%
The Live Chart for Autolus Therapeutics PLC
Profile picture for
            Autolus Therapeutics PLC

AUTL

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of hematological malignancies and solid tumors. The company is developing AUTO1 and AUTO3 for B cell malignancies; AUTO2 for the treatment of multiple myeloma; AUTO4 and AUTO 5 for T cell lymphoma; and AUTO6 and AUTO7 to treat solid tumors. The company was founded in 2014 and is headquartered in London, the United Kingdom.

Last 10 Buy Signals
Date Signal @
UBQUSDJul 3 - 19:350.0337
BLOCKUSDJul 3 - 19:330.182
XCPUSDJul 3 - 19:332.69
USDTUSDJul 3 - 19:320.999
NXTUSDJul 3 - 19:290.0034
DCRUSDJul 3 - 19:2822.63
SALTUSDJul 3 - 19:270.0310
BLOCKUSDJul 3 - 19:240.183
ARDRUSDJul 3 - 19:230.102
KNCUSDJul 3 - 19:221.236

Stock Peers

Company Price Change
AUTL2.75-2.83%
ADAP1.650-2.94%
ALVR4.135.90%
CHMA3.76-6.00%
CLPT12.51-4.14%
CMPI10.500.00%
EDAP6.60-2.94%
FDMT6.96-0.29%
MOLN6.943.18%
OCUL4.091.74%
THTX2.11-7.05%

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.